NASDAQ: KPRXKiora Pharmaceuticals Inc Stock Ownership - Who owns Kiora Pharmaceuticals?
Insider buying vs selling
Have Kiora Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Melissa Tosca | CFO | 2026-07-01 | 911 | $2.66 | $2.42kSell |
| Brian M. Strem | President and CEO | 2026-07-01 | 1,869 | $2.66 | $4.97kSell |
| Brian M. Strem | President and CEO | 2026-04-01 | 1,906 | $1.95 | $3.72kSell |
| Eric Joseph Daniels | Chief Development Officer | 2026-04-01 | 929 | $1.95 | $1.81kSell |
| Melissa Tosca | CFO | 2026-04-01 | 929 | $1.95 | $1.81kSell |
| Brian M. Strem | President and CEO | 2026-03-03 | 238 | $2.02 | $480.76Sell |
| Eric Joseph Daniels | Chief Development Officer | 2026-03-03 | 238 | $2.02 | $480.76Sell |
KPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when KPRX insiders and whales buy or sell their stock.
KPRX Shareholders
What type of owners hold Kiora Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Armistice Capital LLC | 169.02% | 7,478,202 | $20.04M | Insider |
| Innoven Partenaires Sa Ipsa | 33.01% | 1,460,479 | $3.91M | Insider |
| Ventech Capital II | 32.36% | 1,431,814 | $3.84M | Insider |
| Private Equity Natixis | 15.24% | 674,205 | $1.81M | Insider |
| Barbara Wirostko | 10.48% | 463,808 | $1.24M | Insider |
| Michael Garanzini | 4.44% | 196,250 | $525.95k | Insider |
| Franz Obermayr | 2.30% | 101,613 | $272.32k | Insider |
| Paul G. Chaney | 2.06% | 91,229 | $244.49k | Insider |
| Stephen From | 1.53% | 67,693 | $181.42k | Insider |
| Bernard Malfroycamine | 1.39% | 61,525 | $164.89k | Insider |
KPRX vs Biotech Stocks
Kiora Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.